ADENTRA (ADEN) Q1 2025 earnings summary

Executive summary

• Q1 2025 sales rose 1.4% year-over-year to $542.5 million, driven by the Wolf Distributing acquisition, offsetting a 4.7% decline in U.S. organic sales and softness in residential construction.

• Gross margin held steady at 21.6%, reflecting stable pricing and effective procurement despite lower volumes and affordability pressures.

• Adjusted EBITDA was $40 million (7.4% margin), down from $45.6 million last year; adjusted EPS was $0.42, down from $0.76.

• Net income dropped to $4.1 million (EPS $0.16), down 61.4% from $10.7 million (EPS $0.48) in Q1 2024.

• Maintained disciplined cost management, with operating expense increases mainly from the Wolf acquisition and higher warehouse costs.

Financial highlights

• Total sales grew 1.4% year-over-year to $542.5 million, with U.S. organic sales down 4.7% and Canadian sales up 3%.

• Gross margin was 21.6% in Q1, consistent with prior year.

• Adjusted EBITDA margin was 7.4%, down from 8.5% last year.

• Adjusted net income was $10.8 million, down 36.8% year-over-year.

• Operating cash flow was negative due to seasonal inventory build and trade positioning.

Outlook and guidance

• Maintains a conservative near-term outlook due to high U.S. mortgage rates, tight housing supply, trade tensions, and inflation risk.

• Transitioning from fixed 2028/5-year targets to a full-cycle performance framework, focusing on average outcomes across economic cycles.

• Long-term framework targets: low to mid-single-digit organic growth, $50M–$150M annual M&A, gross margin above 20%, adjusted EBITDA margin 8%–10%, and ROIC of 10%–12%.

• Focus on operational efficiency, capital returns, and sustainable EPS growth.